Study of seroPREvalence Vis-à-vis SARS-CoV2 and Correlation With Clinical Forms of COVID-19 in Patients Followed in Pneumology in the Cluster Area of the Grand-Est Region (Strasbourg University Hospital)

Study of seroPREvalence Vis-à-vis SARS-CoV2 and Correlation With Clinical Forms of COVID-19 in Patients Followed in Pneumology in the Cluster Area of the Grand-Est Region (Strasbourg University Hospital)

seroPREvalence vis-à-vis SARS-CoV2 and correlation with clinical forms of COVID-19 in patients followed in Pulmonology in the cluster area of the Grand-Est region.

Inclusion Criteria:

• Man or woman from 18 years old and without upper age limit

• Patient followed in pulmonology at Strasbourg University Hospital

• Patient presenting at least one of the following pathologies:

  1. severe persistent asthma (200 patients)
  2. chest cancer that is active or has received treatment within a period of less than one year (300 patients)
  3. history of lung transplantation performed before the start of the epidemic (02/29/2020) (300 patients)
  4. idiopathic or other diffuse interstitial lung disease, sarcoidosis or vasculitis (70 patients)
  5. pulmonary arterial hypertension (PAH) (group 1 of the international classification) any cause or chronic thromboembolic PAH (group 4): (60 patients)
  6. Severe COPD in the respiratory failure stage (150 patients)

• Subject affiliated to a social health insurance protection scheme

• Subject able to understand the objectives of the research

• Subject having signed an informed consent

Exclusion Criteria:

• Inability to provide informed information about the subject (subject in an emergency situation, difficulty in understanding the subject, etc.)
• Subject under safeguard of justice
• Subject under guardianship or guardianship